PSA Testing for Prostate Cancer
PSA testing is a blood test used to screen for prostate cancer in men. Here are some things to know about PSA testing:
- Who should be screened: The US Preventive Services Task Force (USPSTF) recommends against PSA-based screening for prostate cancer in men who do not have symptoms. However, men who are at high risk for prostate cancer, such as African American men or men with a family history of the disease, may benefit from PSA testing starting at age 45 or 50.
- How it’s done: PSA testing involves a simple blood draw. The blood sample is sent to a laboratory for analysis to determine the level of PSA (prostate-specific antigen) in the blood.
- Benefits of screening: The main benefit of PSA testing is that it can detect prostate cancer early, when it is more treatable. Early detection may also increase the chances of being cured of the disease.
- Risks of screening: There are risks associated with PSA testing, including false-positive results, which can lead to further testing and procedures that may be unnecessary. There is also a risk of overdiagnosis and overtreatment, which can result in complications such as impotence and incontinence.
It’s important to talk to your healthcare provider to determine if PSA testing is right for you. They can help you weigh the potential benefits and risks and discuss any concerns you may have. If you do undergo PSA testing and the results are abnormal, your healthcare provider may recommend further testing, such as a biopsy, to determine if you have prostate cancer.